Monitoring osteoporosis treatment
- 31 December 2009
- journal article
- research article
- Published by Elsevier in Best Practice & Research Clinical Rheumatology
- Vol. 23 (6) , 781-788
- https://doi.org/10.1016/j.berh.2009.09.007
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trialBone, 2008
- Relationship of Early Changes in Bone Resorption to the Reduction in Fracture Risk With Risedronate: Review of Statistical AnalysisJournal of Bone and Mineral Research, 2007
- Once-Yearly Zoledronic Acid for Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 2007
- Changes in Biochemical Markers after Lower Limb FracturesClinical Chemistry, 2007
- Biochemical markers of bone turnover are influenced by recently sustained fractureBone, 2005
- Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal OsteoporosisJournal of Bone and Mineral Research, 2004
- Relationship Between Changes in Bone Mineral Density and Fracture Risk Reduction With Antiresorptive Drugs: Some Issues With Meta-AnalysesJournal of Bone and Mineral Research, 2004
- Osteoporosis Prevention, Diagnosis, and TherapyJAMA, 2001
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Accurate assessment of precision errors: How to measure the reproducibility of bone densitometry techniquesOsteoporosis International, 1995